Hemolytic uremic syndrome (HUS) as a rare complication of induction chemotherapy for acute myeloid leukemia (AML) without maturation

書誌事項

タイトル別名
  • 急性骨髄性白血病寛解導入療法後に発症した溶血性尿毒症性症候群の1例
  • キュウセイ コツズイセイ ハッケツビョウ カンカイ ドウニュウ リョウホウゴ ニ ハッショウ シタ ヨウケツセイ ニョウドクショウセイ ショウコウグン ノ 1レイ

この論文をさがす

抄録

論文(Article)

A 75-year-old male was diagnosed with acute myeloid leukemia without maturation and was treated with combination chemotherapy. After the first remission-induction therapy, he reached complete remission. About one month after the first induction therapy, he was diagnosed with a complication of chemotherapy-related HUS (C-HUS). He gradually recovered from the C-HUS after the initiation of a plasma exchange. In conclusion, it seems that the anti-leukemic drugs might play an important role in the development of chemotherapy C-HUS.

収録刊行物

詳細情報 詳細情報について

問題の指摘

ページトップへ